CASC9 and glioblastoma: The m6A binding protein IGF2BP2 can recognize modification sites on lncRNA CASC9 (cancer susceptibility 9) and enhance its stability, thereby increasing the stability of hexokinase 2 mRNA, which is beneficial for aerobic glycolysis in GBM and promotes GBM proliferation [114].